These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 22835453)
1. How does TGF-β mediate tubulointerstitial fibrosis? Gewin L; Zent R Semin Nephrol; 2012 May; 32(3):228-35. PubMed ID: 22835453 [TBL] [Abstract][Full Text] [Related]
2. Effect of dietary salt on regulation of TGF-β in the kidney. Hovater MB; Sanders PW Semin Nephrol; 2012 May; 32(3):269-76. PubMed ID: 22835458 [TBL] [Abstract][Full Text] [Related]
3. Renal fibrosis is not reduced by blocking transforming growth factor-β signaling in matrix-producing interstitial cells. Neelisetty S; Alford C; Reynolds K; Woodbury L; Nlandu-Khodo S; Yang H; Fogo AB; Hao CM; Harris RC; Zent R; Gewin L Kidney Int; 2015 Sep; 88(3):503-14. PubMed ID: 25760325 [TBL] [Abstract][Full Text] [Related]
4. Heme oxygenase-1 as a target for TGF-β in kidney disease. Zarjou A; Agarwal A Semin Nephrol; 2012 May; 32(3):277-86. PubMed ID: 22835459 [TBL] [Abstract][Full Text] [Related]
5. Curtailing endothelial TGF-β signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD. Xavier S; Vasko R; Matsumoto K; Zullo JA; Chen R; Maizel J; Chander PN; Goligorsky MS J Am Soc Nephrol; 2015 Apr; 26(4):817-29. PubMed ID: 25535303 [TBL] [Abstract][Full Text] [Related]
6. The cellular and signalling alterations conducted by TGF-β contributing to renal fibrosis. Vega G; Alarcón S; San Martín R Cytokine; 2016 Dec; 88():115-125. PubMed ID: 27599257 [TBL] [Abstract][Full Text] [Related]
7. c-Myc promotes renal fibrosis by inducing integrin αv-mediated transforming growth factor-β signaling. Shen Y; Miao N; Wang B; Xu J; Gan X; Xu D; Zhou L; Xue H; Zhang W; Yang L; Lu L Kidney Int; 2017 Oct; 92(4):888-899. PubMed ID: 28483378 [TBL] [Abstract][Full Text] [Related]
8. A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-β/Smad signaling. He X; Cheng R; Huang C; Takahashi Y; Yang Y; Benyajati S; Chen Y; Zhang XA; Ma JX Signal Transduct Target Ther; 2020 Apr; 5(1):45. PubMed ID: 32345960 [TBL] [Abstract][Full Text] [Related]
9. Microvascular endothelial cells poised to take center stage in experimental renal fibrosis. Daehn I; Bottinger EP J Am Soc Nephrol; 2015 Apr; 26(4):767-9. PubMed ID: 25535302 [No Abstract] [Full Text] [Related]
10. Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation. Goto Y; Manabe N; Uchio-Yamada K; Yamaguchi-Yamada M; Inoue N; Yamamoto Y; Ogura A; Nagano N; Miyamoto H Cell Tissue Res; 2004 Feb; 315(2):209-21. PubMed ID: 14615933 [TBL] [Abstract][Full Text] [Related]
11. Renal tubulointerstitial fibrosis. New thoughts on its development and progression. O'Donnell MP Postgrad Med; 2000 Jul; 108(1):159-62, 165, 171-2. PubMed ID: 10914125 [TBL] [Abstract][Full Text] [Related]
12. Kinetics of transforming growth factor-beta1 and extracellular matrix in renal tubulointerstitial lesions of mercuric chloride-treated Brown Norway rats. Suzuki K; Uetsuka K; Nakayama H; Doi K Int J Exp Pathol; 1999 Jun; 80(3):125-32. PubMed ID: 10469268 [TBL] [Abstract][Full Text] [Related]
13. Ureic clearance granule, alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats, compared with enalapril. Huang YR; Wei QX; Wan YG; Sun W; Mao ZM; Chen HL; Meng XJ; Shi XM; Tu Y; Zhu Q J Ethnopharmacol; 2014 Sep; 155(3):1541-52. PubMed ID: 25087615 [TBL] [Abstract][Full Text] [Related]
14. Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis. Yokoi H; Sugawara A; Mukoyama M; Mori K; Makino H; Suganami T; Nagae T; Yahata K; Fujinaga Y; Tanaka I; Nakao K Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S134-8. PubMed ID: 11576939 [TBL] [Abstract][Full Text] [Related]
15. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects. López-Hernández FJ; López-Novoa JM Cell Tissue Res; 2012 Jan; 347(1):141-54. PubMed ID: 22105921 [TBL] [Abstract][Full Text] [Related]
16. Gremlin is a downstream profibrotic mediator of transforming growth factor-beta in cultured renal cells. Rodrigues-Diez R; Lavoz C; Carvajal G; Rayego-Mateos S; Rodrigues Diez RR; Ortiz A; Egido J; Mezzano S; Ruiz-Ortega M Nephron Exp Nephrol; 2012; 122(1-2):62-74. PubMed ID: 23548835 [TBL] [Abstract][Full Text] [Related]
17. Wnt/β-Catenin in Acute Kidney Injury and Progression to Chronic Kidney Disease. Huffstater T; Merryman WD; Gewin LS Semin Nephrol; 2020 Mar; 40(2):126-137. PubMed ID: 32303276 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 stimulates collagen matrix remodeling through increased adhesive and contractive potential by human renal fibroblasts. Kondo S; Kagami S; Urushihara M; Kitamura A; Shimizu M; Strutz F; Müller GA; Kuroda Y Biochim Biophys Acta; 2004 Aug; 1693(2):91-100. PubMed ID: 15313011 [TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. Sato M; Muragaki Y; Saika S; Roberts AB; Ooshima A J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b. Wang B; Jha JC; Hagiwara S; McClelland AD; Jandeleit-Dahm K; Thomas MC; Cooper ME; Kantharidis P Kidney Int; 2014 Feb; 85(2):352-61. PubMed ID: 24088962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]